Paper41559050
TET1 as a master regulator controlling GPX4-dependent and -independent ferroptosis surveillance in acute myeloid leukemia.
Yang L and 11 others. Nat Commun, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. TET1 as a master regulator controlling GPX4-dependent and -independent ferroptosis surveillance in acute myeloid leukemia. Papers, record 41559050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41559050
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TET1 as a master regulator controlling GPX4-dependent and -independent ferroptosis surveillance in acute myeloid leukemia.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Phospholipid Hydroperoxide Glutathione Peroxidase | Major topic |
| Mixed Function Oxygenases | Major topic |
| Humans | |
| Animals | |
| Mice | |
| GTP Cyclohydrolase | |
| Cell Line, Tumor | |
| NF-kappa B | |
| DNA Methylation | |
| Epigenesis, Genetic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32270615 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 81970144 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38378601 | Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/38378601 | PubMed |
| 2 | 34568341 | Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34568341 | PubMed |
| 3 | 28678785 | Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. | Nature | 2017 | https://conductscience.org/library/papers/28678785 | PubMed |
| 4 | 33895792 | RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. | Blood | 2021 | https://conductscience.org/library/papers/33895792 | PubMed |
| 5 | 35874469 | Protocol to establish a stable MLL-AF9_AML mouse model. | STAR Protoc | 2022 | https://conductscience.org/library/papers/35874469 | PubMed |
| 6 | 31056284 | Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke. | Cell | 2019 | https://conductscience.org/library/papers/31056284 | PubMed |
| 7 | 29290465 | Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. | Cell | 2018 | https://conductscience.org/library/papers/29290465 | PubMed |
| 8 | 27308510 | The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. | Mol Cell Oncol | 2015 | https://conductscience.org/library/papers/27308510 | PubMed |
| 9 | 33029587 | Responsive Trimodal Probes for In Vivo Imaging of Liver Inflammation by Coassembly and GSH-Driven Disassembly. | Research (Wash D C) | 2020 | https://conductscience.org/library/papers/33029587 | PubMed |
| 10 | 36309489 | GPX4-independent ferroptosis-a new strategy in disease's therapy. | Cell Death Discov | 2022 | https://conductscience.org/library/papers/36309489 | PubMed |
| 11 | 38016474 | SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. | Mol Cell | 2023 | https://conductscience.org/library/papers/38016474 | PubMed |
| 12 | 37563110 | TET (Ten-eleven translocation) family proteins: structure, biological functions and applications. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37563110 | PubMed |
| 13 | 36152632 | Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming. | Mol Cell | 2022 | https://conductscience.org/library/papers/36152632 | PubMed |
| 14 | 31634899 | FSP1 is a glutathione-independent ferroptosis suppressor. | Nature | 2019 | https://conductscience.org/library/papers/31634899 | PubMed |
| 15 | 28159741 | Biology and relevance of human acute myeloid leukemia stem cells. | Blood | 2017 | https://conductscience.org/library/papers/28159741 | PubMed |
| 16 | 33357455 | Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis. | Cell Metab | 2021 | https://conductscience.org/library/papers/33357455 | PubMed |
| 17 | 30925886 | Ferroptosis, a new form of cell death: opportunities and challenges in cancer. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/30925886 | PubMed |
| 18 | 32413317 | Emerging Mechanisms and Disease Relevance of Ferroptosis. | Trends Cell Biol | 2020 | https://conductscience.org/library/papers/32413317 | PubMed |
| 19 | 37438601 | Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy. | Cell Oncol (Dordr) | 2023 | https://conductscience.org/library/papers/37438601 | PubMed |
| 20 | 37229485 | The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37229485 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42928985 | Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI-CKD. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42928985 |
Source PubMed
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCH1 | 2643 | PubTator's text mining | https://conductscience.org/library/genes/2643 | NCBI Gene |
| GCLC | 2729 | PubTator's text mining | https://conductscience.org/library/genes/2729 | NCBI Gene |
| GPX4 | 2879 | PubTator's text mining | https://conductscience.org/library/genes/2879 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TET1 | 80312 | PubTator's text mining | https://conductscience.org/library/genes/80312 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41559050
GET https://conductscience.org/api/papers/v1/41559050/references?page=2